Real-time enrollment status for this retroperitoneal sarcoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:36 AM UTC
| NCT Number | NCT01659203 |
| Recruiting Status | Recruiting |
| Condition | Retroperitoneal Sarcoma |
| Phase | Clinical Trial |
| Target Enrollment | 80 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | March 19, 2026 (Mar 19, 2026) |
As of July 13, 2026: Clinical trial NCT01659203 is currently recruiting participants. This clinical trial study for retroperitoneal sarcoma is actively seeking new participants at 10 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01659203 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01659203 was last updated Mar 19, 2026 (March 19, 2026). HelloStudys verifies this status automatically.